Canadian application, no grantCanada
Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof
CA 2364002 A1 · Owner: Fondazione Centro San Raffaele Del Monte Tabor · Inventors: Dellabona, Paolo; Protti, Maria Pia
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Peptides derived from the protein MAGE-3 pharmaceutical compositions , containing them and the use thereof for inducing an immune response against tumors.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 23, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 23, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 23, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 23, 2000
GrantedNo grant recorded
Term endedFebruary 23, 2020
Patent numberCA 2364002 A1
Classification (IPC)C07K14/47 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.